Mesothelioma Active Supervision:
If prostate cancer is in its early stages and grows slowly. Treating cancer can cause more problems than the disease itself. And doctors may recommend active mesothelioma surveillance or observation waiting.
Prostate cancer treatment can cause side effects such as erectile dysfunction. Ie, erection, and maintenance of erections. As well as incontinence, ie, inability to control urinary flow or bowel function.
These methods of treating prostate cancer can seriously affect the quality of life of men. In addition, many prostate cancers grow slowly and do not cause any symptoms or problems. For this reason, many men may consider delaying cancer treatment rather than starting treatment immediately. This is called active monitoring.
During the active monitoring period, cancer is closely monitored for signs of deterioration. If the cancer is found to be worse, treatment will begin.
For men with low-risk prostate cancer, active monitoring is usually the first choice. If symptoms worsen, they can be treated with surgery or radiation therapy. ASCO endorses the Ontario Cancer Medical Center‘s recommendation for active surveillance.
Which recommends active monitoring of most patients with a Gleason score of 6 or less, with cancer not spreading beyond the prostate. Sometimes, active monitoring may be the choice of a male with a Gleason score of 7.
You may like to read about how to hire a mesothelioma lawyer.
Genomic testing is also being used to help determine if proactive monitoring is the best option for prostate cancer patients.
ASCO encourages the following proactive monitoring test programs:
- PSA testing every 3 to 6 months
- DRE at least once a year
- Perform another prostate biopsy within 6 to 12 months. And then perform a biopsy at least every 2 to 5 years
If the test results performed during active monitoring indicate that cancer has become more aggressive or spread. Causing pain or occlusion of the urinary tract, the patient should be treated.
For older men and those with other serious or life-threatening illnesses. That is expected to live for less than five years, observational waiting may be an option. By observing the wait, conventional PSA tests, DRE and biopsy usually do not perform well.
If the patient has symptoms of prostate cancer. Such as pain or urinary tract obstruction, treatment may be recommended to alleviate symptoms. This may include ADT. Men who begin proactive surveillance and have a short life expectancy may turn to observations at some point to avoid repeated testing and biopsy.
Doctors must be cautious when judging the disease. In other words, the doctor must collect as much information as possible about the patient’s other illnesses and life expectancy. To determine if active monitoring or observation is appropriate for each patient.
In addition, many doctors recommend repeat biopsies shortly after diagnosis. It is to confirm that cancer is at an early stage and grow slowly. Before considering active monitoring of healthy people.